AMPH
Amphastar Pharmaceuticals Stock Analysis
AI Rating
- Quality9/10
- Growth↓ 0/10
- Momentum↓ 4/10
AMPH Growth
- Revenue Y/Y↓ -0.03%
- EPS Y/Y↓ -27.38%
- FCF Y/Y↓ -33.44%
AMPH Profitability
- Gross margin ↑ 49.40%
- EPS margin↑ 15.40%
- ROIC↓ 12.20%
AMPH Risk
- Debt / Equity↓ 0.8
- Debt / FCF↓ 3.9
- Interest coverage↑ 6.4
Amphastar Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.